Lipidor AB Logo

Lipidor AB

Develops topical skin treatments by reformulating drugs with a lipid-based delivery platform.

LIPI | ST

Overview

Corporate Details

ISIN(s):
SE0012558617 (+1 more)
LEI:
549300OC9DDXCE1GMX60
Country:
Sweden
Address:
C/O Ekonomistubben AB, 102 16 Stockholm
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Lipidor AB is a pharmaceutical research and development company specializing in topical treatments for skin diseases. The company's core asset is its proprietary lipid-based drug delivery platform, AKVANO®. Lipidor's business model focuses on reformulating existing active pharmaceutical ingredients into new, innovative, and patient-friendly treatments. This approach offers an accelerated path to regulatory approval and commercialization for its global pharmaceutical partners. The AKVANO® platform is designed to enhance patient compliance by creating formulations that are easy to apply, quick-drying, and less likely to cause skin irritation. The company maintains a pipeline of development projects in various pre-clinical and clinical phases for a wide range of dermatological conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Lipidor AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Lipidor AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Lipidor AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Chordia Therapeutics,Inc Logo
Developing first-in-class, small-molecule anti-cancer drugs targeting RNA deregulation.
Japan 190A
CHOSA Oncology AB Logo
Develops diagnostics and targeted therapies to personalize platinum-based cancer treatments.
Sweden CHOSA
CINC Corp. Logo
Offers AI marketing analytics and SEO tools leveraging a vast Japanese keyword dataset.
Japan 4378
CIRCULATION Co.,Ltd. Logo
Connects corporations with experts for project-based consulting to solve business challenges.
Japan 7379
CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo
Developing a CIZ1B biomarker blood test for the early detection of lung cancer.
United Kingdom CIZ
COPRO-HOLDINGS. Co., Ltd. Logo
Dispatches technical personnel to Japan's construction & plant industries.
Japan 7059
A creator agency connecting professionals in creative, tech, medical, and legal sectors.
Japan 4763
Offers IT solutions to financial institutions and develops vaccines for HIV and coronaviruses.
South Korea 040350
CRG HOLDINGS CO.,LTD. Logo
Provides IT-driven HR services, outsourcing, system solutions, and financial advisory.
Japan 7041
CRONEX.CO.,LTD Logo
CRO supplying mini-pigs and bio-tissues for non-clinical R&D in medical and cosmetic industries.
South Korea 215570

Talk to a Data Expert

Have a question? We'll get back to you promptly.